Author

D. Morzaev-Sulzbach

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

M. Dadiani· 2 shared A. Ben-Shmuel· 1 shared A. Pavlovski· 1 shared A. Shenoy· 1 shared B. Kaufman· 1 shared E. Domany· 1 shared E. Gal-Yam· 1 shared E. N. Gal-Yam· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. Dadiani

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer-associated fibroblasts serve as decoys to suppress NK cell anti-cancer cytotoxicity

A. Ben-Shmuel, Y. Gruper, O. Levi-Galibov, H. Rosenberg-Fogler, G. Carradori, Y. Stein, M. Dadiani, M. Naumova, R. Nevo, D. Morzaev-Sulzbach, G. Yagel, S. Mayer, E. Gal-Yam, R. Scherz-Shouval

The paper shows cancer-associated fibroblasts suppress NK cell cytotoxicity by acting as decoys, leading to poor disease outcomes in breast cancer.

bioRxiv · Nov 23, 2023 · PreprintCancer Biology

Chemoresistome Mapping in Individual Breast Cancer Patients Unravels Diversity in Dynamic Transcriptional Adaptation

M. Dadiani, G. Friedlander, G. Perry, N. Balint-Lahat, S. Gilad, D. Morzaev-Sulzbach, N. Bossel Ben-Moshe, A. Pavlovski, E. Domany, A. Shenoy, I. Barshack, T. Geiger, B. Kaufman, E. N. Gal-Yam

The paper maps chemoresistome dynamics in breast cancer patients to identify patient-specific resistance mechanisms and vulnerabilities.

bioRxiv · Feb 9, 2023Cancer Biology